Volume 14, Number 8—August 2008
Research
Genetic and Serologic Properties of Zika Virus Associated with an Epidemic, Yap State, Micronesia, 2007
Table 3
Primer | Genome position† | Sequence (5′ → 3′) | Sensitivity, no. copies | Specificity‡ |
---|---|---|---|---|
ZIKV 835 | 835–857 | TTGGTCATGATACTGCTGATTGC | ||
ZIKV 911c | 911–890 | CCTTCCACAAAGTCCCTATTGC | 100 | ZIKV |
ZIKV 860-FAM | 860–886 | CGGCATACAGCATCAGGTGCATAGGAG | ||
ZIKV 1086 | 1086–1102 | CCGCTGCCCAACACAAG | ||
ZIKV 1162c | 1162–1139 | CCACTAACGTTCTTTTGCAGACAT | 25 | ZIKV |
ZIKV 1107-FAM | 1107–1137 | AGCCTACCTTGACAAGCAGTCAGACACTCAA |
*RT-PCR, reverse transcription–PCR; ZIKV, Zika virus.
†Based on ZIKV MR 766 GenBank accession no. AY632535.
‡ZIKV specificity indicates a positive result with ZIKV only and no reactivity with dengue virus-1 (DENV-1), DENV-2, DENV-3, DENV-4, West Nile virus, St. Louis encephalitis virus, yellow fever virus, Powassan virus, Semliki Forest virus, o’nyong-nyong virus, chikungunya virus, and Spondweni virus.
Page created: July 13, 2010
Page updated: July 13, 2010
Page reviewed: July 13, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.